I-2-Hydroxy-5-Methylpyridine CAS 1003-68-5 Ubunyulu ≥99.0% iPirfenidone Intermediate Factory

Inkcazelo emfutshane:

Igama leKhemikhali: 2-Hydroxy-5-Methylpyridine

Izithethantonye: 5-Methyl-2(1H)-Pyridinone

CAS: 1003-68-5

Ubunyulu: ≥99.0%

Imbonakalo: Okumhlophe-kuMhlophe ukuya kumgubo weCrystalline otyheli

Phakathi kwePirfenidone (CAS: 53179-13-8) ukunyanga i-Idiopathic Pulmonary Fibrosis (IPF)

E-Mail: alvin@ruifuchem.com


Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo lwabavelisi, ubunyulu obuphezulu, iMveliso yoRhwebo
Igama leKhemikhali: 2-Hydroxy-5-Methylpyridine
CAS: 1003-68-5

Iipropati zeMichiza:

Igama leMchiza I-2-Hydroxy-5-Methylpyridine
Izithethantonye 5-Methyl-2(1H)-Pyridinone;I-2-Hydroxy-5-Picoline;I-6-Hydroxy-3-Picoline;5-Methyl-2-Pyridinol
Inombolo yeCAS 1003-68-5
Inombolo yeCAT RF-PI549
Ubume beStokhwe Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli C6H7NO
Ubunzima beMolekyuli 109.13
Indawo yokunyibilika 183.0 ukuya 187.0℃ (lit.)
Ukunyibilika Inyibilika kwiMethanol
Uphawu Ruifu Chemical

Iinkcukacha:

Into Iinkcukacha
Imbonakalo Okumhlophe-kuMhlophe ukuya koMthubi wePowder yeCrystalline
Ubunyulu ≥99.0%
Isiqulatho sokufuma (KF) ≤0.50%
Intsalela kwi-Ignition ≤0.50%
Nakuphi na Ukungacoceki Okukodwa ≤0.50%
Ukungcola ngokupheleleyo ≤1.00%
Izinyibilikisi ezishiyekileyo
n-Butanol ≤0.30%
I-Ethanol ≤0.30%
Umgangatho woVavanyo Umgangatho woShishino
Ukusetyenziswa Umbindi wePirfenidone (CAS: 53179-13-8)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma

Izinto eziluncedo:

1

FAQ:

Isicelo:

I-2-Hydroxy-5-Methylpyridine (i-CAS: 1003-68-5) isetyenziswe njenge-pharmaceutical intermediate ye-Pirfenidone (CAS: 53179-13-8).I-Pirfenidone (PFD) luhlobo lwenoveli ye-pyridine ketones ene-wide-spectrum anti-fibrotic effect, ekwazi ukuthintela kunye nokubuyisela umva ukubunjwa kwe-fibrosis kunye nesiva.Yangena kwimarike eShionogi, eJapan ngo-2008 kwaye yamkelwe yi-US yokutya kunye noLawulo lweziyobisi.Lichiza lokuqala eliye ladlula kwisigaba sesi-III solingo lwezonyango (kubandakanya ukuphindaphinda, ukungakhethi, kunye nolawulo lwe-placebo) olubonise ukusebenza kwalo ekunyangeni i-idiopathic pulmonary fibrosis (IPF);ngaphezu koko, iyeza lisebenza kakuhle ekunyangeni izifo ezithile zefibrotic ezifana ne-renal interstitial fibrosis kunye ne-liver fibrosis.

Bhala umyalezo wakho apha kwaye uwuthumele kuthi